Physician

Daniel John Lorenzana, MD

According to 2025 Medicare claims, Daniel Lorenzana, MD (NPI: 1073048328) practices hand surgery in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is PREMIER ORTHOPAEDIC AND SPORTS MEDICINE ASSOCIATES, LTD (NPI: 1215987243; TIN: 232866529) and primary practice location at 19148-3542.

Lorenzana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 213 traditional Medicare patients, billed 2,001 HCPCS/CPT codes, and received $63,819 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 233 prescription claims across 96 beneficiaries totaling $2,269 in drug costs, led by Meloxicam (Meloxicam). Open Payments data shows 13 records totaling $2,578. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $808 to $2,269. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$32K$64K2023 Medicare payment: $10,501 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $63,819 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202358150$10,501
20242132,001$63,819

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1K$2.3K2018 Drug cost: $808 (USD; Tot_Drug_Cst)2019 Drug cost: $1,872 (USD; Tot_Drug_Cst)2020 Drug cost: $1,635 (USD; Tot_Drug_Cst)2021 Drug cost: $437 (USD; Tot_Drug_Cst)2022 Drug cost: $284 (USD; Tot_Drug_Cst)2023 Drug cost: $112 (USD; Tot_Drug_Cst)2024 Drug cost: $2,269 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182342$808
20192033$1,872
20202335$1,635
20213250$437
2022N/R12$284
20232325$112
202496233$2,269

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more135229$70
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more9898$70
20610Aspiration and/or injection of fluid from large joint6189$54
73030X-ray of shoulder, minimum of 2 views6277$27
J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg90374$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MeloxicamMeloxicam621,870$183
Tramadol HclTramadol Hcl48255$115
CelecoxibCelecoxib11522$105
Oxycodone HclOxycodone Hcl28110$93
MethylprednisoloneMethylprednisolone1590$84

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$2,578Shoulder Innovations, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel John Lorenzana, MD?

Tedicare shows public-source Medicare data for Daniel John Lorenzana, MD (NPI 1073048328), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel John Lorenzana, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel John Lorenzana, MD?

Daniel John Lorenzana, MD is linked to PREMIER ORTHOPAEDIC AND SPORTS MEDICINE ASSOCIATES, LTD (billing NPI 1215987243) in the available physician profile data.

Does Daniel John Lorenzana, MD have Open Payments data?

Daniel John Lorenzana, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.